Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo
Ramesh Elango(Hamad bin Khalifa University), Nehad M. Alajez(King Saud University)
Cited by 23
Related Papers
Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98
|Cell Death and Disease|2010|158
Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy
|Cell Death and Differentiation|2009|75
In vitro differentiation of human skin-derived multipotent stromal cells into putative endothelial-like cells
|BMC Developmental Biology|2012|63
Epigenetic Library Screen Identifies Abexinostat as Novel Regulator of Adipocytic and Osteoblastic Differentiation of Human Skeletal (Mesenchymal) Stem Cells
|Stem Cells Translational Medicine|2016|33